Effects of olopatadine hydrochloride, a histamine [H.sub.1] receptor antagonist, on histamine-induced skin responses
Effects of olopatadine hydrochloride, a histamine Hi receptor antagonist, on histamine-induced skin responses were evaluated in 10 healthy subjects in comparison with placebo, fexofenadine hydrochloride, and bepotastine besilate. Olopatadine significantly suppressed histamine-induced wheal, flare, a...
Saved in:
Published in | Dermatology research and practice |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
John Wiley & Sons, Inc
01.01.2010
|
Subjects | |
Online Access | Get full text |
ISSN | 1687-6105 |
DOI | 10.1155/2010/638051 |
Cover
Summary: | Effects of olopatadine hydrochloride, a histamine Hi receptor antagonist, on histamine-induced skin responses were evaluated in 10 healthy subjects in comparison with placebo, fexofenadine hydrochloride, and bepotastine besilate. Olopatadine significantly suppressed histamine-induced wheal, flare, and itch, starting 30 minutes after oral administration. Olopatadine was more effective than fexofenadine and bepotastine. None of the drugs studied impaired performance of word processing tasks. These results suggest that olopatadine can suppress skin symptoms caused by histamine soon after administration. |
---|---|
ISSN: | 1687-6105 |
DOI: | 10.1155/2010/638051 |